271 related articles for article (PubMed ID: 24343521)
1. Inflammatory mechanisms in atherosclerosis.
Wolf D; Stachon P; Bode C; Zirlik A
Hamostaseologie; 2014; 34(1):63-71. PubMed ID: 24343521
[TBL] [Abstract][Full Text] [Related]
2. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.
Huang XS; Zhao SP; Hu M; Luo YP
Med Hypotheses; 2007; 69(1):136-40. PubMed ID: 17218068
[TBL] [Abstract][Full Text] [Related]
4. B cells and atherosclerosis.
Srikakulapu P; McNamara CA
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H1060-H1067. PubMed ID: 28314764
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction as an early sign of atherosclerosis.
Giannotti G; Landmesser U
Herz; 2007 Oct; 32(7):568-72. PubMed ID: 17972030
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and coagulation in atherosclerosis.
Krychtiuk KA; Kastl SP; Speidl WS; Wojta J
Hamostaseologie; 2013; 33(4):269-82. PubMed ID: 24043155
[TBL] [Abstract][Full Text] [Related]
7. An inflammatory link in atherosclerosis and obesity. Co-stimulatory molecules.
Zirlik A; Lutgens E
Hamostaseologie; 2015; 35(3):272-8. PubMed ID: 26225729
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome, inflammation and atherothrombosis.
Rohla M; Weiss TW
Hamostaseologie; 2013; 33(4):283-94. PubMed ID: 23979637
[TBL] [Abstract][Full Text] [Related]
9. Modeling immune system control of atherogenesis.
Pappalardo F; Musumeci S; Motta S
Bioinformatics; 2008 Aug; 24(15):1715-21. PubMed ID: 18556669
[TBL] [Abstract][Full Text] [Related]
10. Atherogenesis - tried and tested pieces in the puzzle.
Scharf RE
Hamostaseologie; 2016 May; 36(2):73-4. PubMed ID: 27163332
[No Abstract] [Full Text] [Related]
11. Targeting inflammation in cardiovascular diseases. still a neglected field?
Gómez-Guerrero C; Mallavia B; Egido J
Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
[TBL] [Abstract][Full Text] [Related]
12. Danger signaling in atherosclerosis.
Zimmer S; Grebe A; Latz E
Circ Res; 2015 Jan; 116(2):323-40. PubMed ID: 25593277
[TBL] [Abstract][Full Text] [Related]
13. The role of monocytes in atherosclerotic coronary artery disease.
Pamukcu B; Lip GY; Devitt A; Griffiths H; Shantsila E
Ann Med; 2010 Sep; 42(6):394-403. PubMed ID: 20568979
[TBL] [Abstract][Full Text] [Related]
14. Analysis of inflammation.
Schmid-Schönbein GW
Annu Rev Biomed Eng; 2006; 8():93-131. PubMed ID: 16834553
[TBL] [Abstract][Full Text] [Related]
15. Innate immune signals in atherosclerosis.
Lundberg AM; Hansson GK
Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
Späh F
Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
[TBL] [Abstract][Full Text] [Related]
17. Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.
Loppnow H; Buerke M; Werdan K; Rose-John S
J Cell Mol Med; 2011 Mar; 15(3):484-500. PubMed ID: 21199323
[TBL] [Abstract][Full Text] [Related]
18. Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?
Jager NA; Teteloshvili N; Zeebregts CJ; Westra J; Bijl M
Autoimmun Rev; 2012 Jul; 11(9):621-6. PubMed ID: 22094710
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and atherosclerosis.
Hansson GK; Robertson AK; Söderberg-Nauclér C
Annu Rev Pathol; 2006; 1():297-329. PubMed ID: 18039117
[TBL] [Abstract][Full Text] [Related]
20. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation.
Lundberg AM; Yan ZQ
Curr Opin Lipidol; 2011 Oct; 22(5):343-9. PubMed ID: 21881501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
